Our News and Events

Come meet us at an upcoming event.

March 25-27, 2019   BIO-Europe Spring
Vienna, Austria

March 26-28, 2019   China Healthcare Investment Conference
Shanghai, China

March 27-28, 2019   MassBIO Annual meeting
Cambridge, MA

March 29 - April 3, 2019   American Association for Cancer Research (AACR) Annual Meeting
Atlanta, Georgia

April 10-14, 2019   The International Liver Congress/EASL- European Association Study Liver
Vienna, Austria

April 13-16, 2019   ECCMID
Amsterdam, The Netherlands

April 14-17, 2019   World Vaccine Congress Washington
Washington, D.C.

April 17-19, 2019   BIO Korea International Convention
Seoul, Korea

April 28 - May 2, 2019   ARVO - Association Research Vision & Ophthamology Annual Meeting
Vancouver, Canada

April 29 - May 1, 2019   BioTrinity 2019
London, UK

May 8-9, 2019   ChinaBio Partnering Forum (sponsored by EBD)
Shanghai, China

May 9-10, 2019   Convergence Forum
Chatham, MA

May 20-21, 2019   BioEquity Europe
Barcelona, Spain

May 31 - June 4, 2019   American Society Of Clinical Oncology (ASCO) Annual Meeting
Chicago, IL

June 3-6, 2019   BIO International 2019
Philadelphia, PA

June 7-11, 2019   ADA - American Diabetes Association Annual Scientific Sessions
San Francisco, CA

August 31 - September 4, 2019   European Society of Cardiology Meeting (ESC Congress 2018)
Paris, France

September 10-12, 2019   Nordic Life Science Days
Malmö, Sweden

September 11-12, 2019   BioPharm America
Boston, MA

September 27 - October 1, 2019   ESMO Congress
Barcelona, Spain

October 2-6, 2019   ID Week
Washington, D.C.

October 15-19, 2019   19th Annual Biotech in Europe Forum (Sachs)
Basel, Switzerland

October 19-23, 2019   Society for Neurosciences (SfN)
San Francisco, CA

October 20-23, 2019   LES Annual Meeting
Phoenix, Arizona

October 22-23, 2019   BIO Investor Forum
San Francisco, CA

October 23-25, 2019   BioNetwork West
Languna Nigel, CA

October 30 - November 1, 2019   AusBiotech
Melbourne, Australia

October 30 - November 3, 2019   SITC 2019
Prince Georges, MD

November 11-13, 2019   BIO-Europe Fall 2019
Hamburg, Germany

November 16-18, 2019   American Heart Association (AHA)
Philadelphia, PA

December 7-10, 2019   ASH Annual Meeting
Orlando, FL

December 11, 2019   Genesis
Westminster, UK

February 21, 2019   Merck to Acquire Immune Design, Acquisition Bolsters Capabilities in Vaccine Development for Infectious Diseases and Cancer
January 3, 2019   Merck Exercises Option for NGM Bio’s Investigational Insulin Sensitizer, NGM313, for the Treatment of NASH and Type 2 Diabetes
January 3, 2019   Amunix Announces Licensing Agreement with Merck for ProTIA Immune Activator Platform
January 3, 2019   Cocrystal Pharma Announces Exclusive Worldwide License and Collaboration Agreement with Merck
October 8, 2018   ImaginAb Announces Collaboration with Merck for CD8 T cell I/O Imaging Agent
October 1, 2018   Dragonfly Therapeutics Announces New Multi-Target Collaboration with Merck to Use Dragonfly's Proprietary TriNKET™ Platform to Develop Novel Drug Candidates for Patients with Solid Tumors
July 24, 2018   Sutro Biopharma Collaborates with Merck to Develop Therapeutics for Cancer and Autoimmune Disorders
July 12, 2018   Pfenex Receives Milestone From Merck Associated With Clinical Advancement of Investigational 15-valent Pneumococcal Vaccine PCV-15 (V114)
July 12, 2018   Cue Biopharma Produces Immuno-STAT™ Biologic Candidate for Treatment of Autoimmune Disease Under Collaboration and License Agreement with Merck
May 3, 2018   Moderna and Merck Expand mRNA Cancer Vaccines Collaboration
March 7, 2018   Eisai Co., Ltd. and Merck Enter Global Strategic Oncology Collaboration for LENVIMA® (lenvatinib mesylate)
February 21, 2018   Merck and Viralytics Announce Acquisition Agreement, Expanding Merck’s Leading Immuno-Oncology Pipeline
November 16, 2017   Cue Biopharma Announces Strategic Research Collaboration and License Agreement with Merck
October 10, 2017   KalVista Pharmaceuticals Announces Collaboration with Merck
September 6, 2017   Merck to Acquire Rigontec, RIG-I Therapeutics Pioneer, Advancing Leadership in Immuno-Oncology
July 27, 2017   AstraZeneca and Merck Establish Strategic Oncology Collaboration
June 20, 2017   SerImmune Inc. Announces Discovery and Development Collaboration with Merck
May 25, 2017   Merck Enters Exclusive Worldwide License Agreement with Teijin Pharma for Investigational Antibody Candidate Targeting Tau
March 17, 2017   New partnership to accelerate development of treatments for neurological diseases
March 1, 2017   GRAIL Closes Over $900 Million Initial Investment in Series B Financing to Develop Blood Tests to Detect Cancer Early
January 5, 2017   Cerveau Technologies, Inc. Signs License Agreement with Merck for Novel Investigational Tau Imaging Agent